Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

NCT07401199 · clinicaltrials.gov ↗

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer (GC)
Locally Advanced Gastric Cancer

Interventions

DRUG: Standard of Care PD-1 Inhibitors
DIAGNOSTIC_TEST: Multimodal AI Assessment

Sponsor

Qun Zhao

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]